| Literature DB >> 36061785 |
Jung Min Kim1,2, Jae Il Lyu3, Dong-Gun Kim1, Nguyen Ngoc Hung1,2, Ji Su Seo1,2, Joon-Woo Ahn1, You Jin Lim4, Seok Hyun Eom4, Bo-Keun Ha2, Soon-Jae Kwon1.
Abstract
Isoflavones are major secondary metabolites that are exclusively produced by legumes, including soybean. Soy isoflavones play important roles in human health as well as in the plant defense system. The isoflavone content is influenced by minor-effect quantitative trait loci, which interact with polygenetic and environmental factors. It has been difficult to clarify the regulation of isoflavone biosynthesis because of its complex heritability and the influence of external factors. Here, using a genotype-by-sequencing-based genome-wide association mapping study, 189 mutant soybean genotypes (the mutant diversity pool, MDP) were genotyped on the basis of 25,646 high-quality single nucleotide polymorphisms (SNPs) with minor allele frequency of >0.01 except for missing data. All the accessions were phenotyped by determining the contents of 12 isoflavones in the soybean seeds in two consecutive years (2020 and 2021). Then, quantitative trait nucleotides (QTNs) related to isoflavone contents were identified and validated using multi-locus GWAS models. A total of 112 and 46 QTNs related to isoflavone contents were detected by multiple MLM-based models in 2020 and 2021, respectively. Of these, 12 and 5 QTNs were related to more than two types of isoflavones in 2020 and 2021, respectively. Forty-four QTNs were detected within the 441-Kb physical interval surrounding Gm05:38940662. Of them, four QTNs (Gm05:38936166, Gm05:38936167, Gm05:38940662, and Gm05:38940717) were located at Glyma.05g206900 and Glyma.05g207000, which encode glutathione S-transferase THETA 1 (GmGSTT1), as determined from previous quantitative trait loci annotations and the literature. We detected substantial differences in the transcript levels of GmGSTT1 and two other core genes (IFS1 and IFS2) in the isoflavone biosynthetic pathway between the original cultivar and its mutant. The results of this study provide new information about the factors affecting isoflavone contents in soybean seeds and will be useful for breeding soybean lines with high and stable concentrations of isoflavones.Entities:
Keywords: GBS; GWAS; Isoflavone; MDP; QTLs; SNPs
Year: 2022 PMID: 36061785 PMCID: PMC9433930 DOI: 10.3389/fpls.2022.968466
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 6.627
FIGURE 1Frequency distribution of individual isoflavones and total isoflavone contents in mutant diversity pool (MDP).
Descriptive statistics, ANOVA analysis, and broad-sense heritability of isoflavone contents in MDP.
| Trait | Year | Min | Max | SD | Mean | Effects | Skewness | Kurtosis |
| ||
| g | y | g × y | |||||||||
| DZE | 2020 | 1.33 | 23.26 | 3.40 | 6.14 |
|
|
| 1.71 | 4.28 | 0.51 |
| 2021 | 0.48 | 32.66 | 4.47 | 4.67 | 3.73 | 18.05 | |||||
| GLE | 2020 | 5.61 | 30.40 | 4.00 | 14.66 |
|
|
| 0.86 | 1.56 | 0.15 |
| 2021 | 0.33 | 31.53 | 3.66 | 2.80 | 4.28 | 23.77 | |||||
| GNE | 2020 | 2.62 | 22.35 | 3.15 | 7.85 |
|
|
| 1.15 | 1.92 | 0.47 |
| 2021 | 1.00 | 44.04 | 5.61 | 6.75 | 3.19 | 14.91 | |||||
| DZI | 2020 | 88.15 | 866.08 | 142.15 | 309.14 |
|
|
| 1.11 | 1.37 | 0.81 |
| 2021 | 33.82 | 525.19 | 102.75 | 168.45 | 1.25 | 1.28 | |||||
| GLI | 2020 | 20.83 | 352.50 | 68.98 | 128.96 |
|
|
| 0.76 | 0.19 | 0.78 |
| 2021 | 28.86 | 282.53 | 51.71 | 109.00 | 0.87 | 0.41 | |||||
| GNI | 2020 | 119.38 | 1097.23 | 165.12 | 421.80 |
|
|
| 1.15 | 1.68 | 0.81 |
| 2021 | 62.30 | 822.62 | 138.84 | 252.62 | 1.33 | 1.97 | |||||
| MDZI | 2020 | 264.50 | 2254.16 | 341.12 | 796.50 |
|
|
| 1.32 | 2.52 | 0.82 |
| 2021 | 177.22 | 1757.39 | 302.93 | 602.93 | 1.02 | 1.12 | |||||
| MGLI | 2020 | 22.98 | 681.26 | 115.17 | 229.07 |
| ns |
| 0.90 | 0.72 | 0.77 |
| 2021 | 52.15 | 535.40 | 101.86 | 226.86 | 0.61 | –0.21 | |||||
| MGNI | 2020 | 256.15 | 2628.58 | 377.59 | 1070.55 |
|
|
| 1.09 | 1.91 | 0.85 |
| 2021 | 172.84 | 2295.43 | 404.65 | 885.91 | 0.81 | 0.64 | |||||
| ADZI | 2020 | 26.89 | 271.71 | 40.56 | 117.03 |
|
|
| 0.96 | 1.59 | 0.86 |
| 2021 | 20.68 | 217.18 | 39.14 | 88.59 | 0.76 | 0.31 | |||||
| AGNI | 2020 | 0.89 | 7.43 | 1.31 | 3.08 |
|
|
| 0.80 | 0.49 | 0.25 |
| 2021 | 0 | 17.46 | 1.93 | 2.41 | 3.16 | 20.21 | |||||
| TI | 2020 | 1032.95 | 6993.06 | 1129.29 | 3104.80 |
|
|
| 0.90 | 0.81 | 0.86 |
| 2021 | 617.35 | 5844.52 | 1036.56 | 2350.98 | 0.74 | 0.17 | |||||
DZE = daidzein; GLE, glycitein; GNE, Genistein; DZI, daidzin; GLI, glycitin; GNI, genistin; MDZI, malonyl daidzin; MGLI, malonyl glycitin; MGNI, malonyl genistin; ADGI, acetyl daidzin; AGLI, acetyl glycitin; AGNI, acetyl genistin; ns, not significant; H2, broad-sense heritability. *** significant at p < 0.001.
a μg g–1.
b g means the genotype effects.
c y means the year effects.
d g × y means the genotype by year effects.
FIGURE 2Correlation analyses among individual isoflavones and total isoflavones. Correlation coefficient in upper panel relates to isoflavone content data from 2021; that in lower panel relates to isoflavone content data from 2020. *, **, ***, and indicate significance at p < 0.05, 0.01, 0.001, and not significant, respectively.
FIGURE 3Manhattan and QQ plots for isoflavone contents in 2020 in the MDP using MLM and mrMLM.
FIGURE 4Manhattan and QQ plots for isoflavone contents in 2021 in the MDP using MLM and mrMLM.
Information about co-detected QTNs for isoflavone contents in 2020 using MLM-based models.
| QTN | Trait | Chr | Position (bp) | Effect | -log10(P) | R2 | MAF | Allele | Method | Candidate gene | Symbol | Description | References |
| Gm02:38740302 | GLE | 2 | 38740302 | 4.34 ∼6.41 | 6.25 ∼10.26 | 1.67 ∼17.25 | 0.50 | C/A | 1, 2, 4, 6 | Glyma.02g202300 | Pseudouridine synthase family protein | ||
| GNI | 263.71 ∼307.91 | 5.78 ∼12.16 | 13.07 ∼22.36 | 0.02 ∼0.50 | 4, 6, 7 | ||||||||
| MGNI | 465.57, 504.72 | 6.07, 7.48 | 2.12, 9.9 | 0.50 | 1, 4 | ||||||||
| ADZI | 59.96 | 11.40 | 9.75 | 0.50 | 4 | ||||||||
| TI | 1199.89 ∼1680.98 | 6.40 ∼9.15 | 2.82 ∼15.73 | 0.50 | 1, 2, 4, 6 | ||||||||
| Gm04:26325280 | DZI | 4 | 26325280 | –58.85 | 7.60 | 7.48 | 0.20 | A/T | 1 | Glyma.04g144300 | ENO1 | Enolase 1 |
|
| MDZI | –179.27 | 12.73 | 5.74 | 0.20 | 1 | ||||||||
| TI | –428.11 | 6.96 | 3.64 | 0.20 | 1 | ||||||||
| Gm04:30558742 | DZI | 4 | 30558742 | 351.75, 385.37 | 6.13 ∼7.23 | 10.04 ∼10.72 | 0.50 | C/T | 2, 4, 6 | ||||
| MDZI | 750.06 ∼891.52 | 6.25, 10.9 | 8.02, 8.56 | 0.50 | 2, 4 | ||||||||
| MGNI | 831.46, 843.02 | 5.78, 5.93 | 7.01, 9.87 | 0.50 | 4,6 | ||||||||
| ADZI | 77.35 | 6.14 | 4.12 | 0.50 | 4 | ||||||||
| TI | 2331.81 ∼2665.47 | 6.54 ∼8.49 | 6.04 ∼9.9 | 0.50 | 2, 4, 6 | ||||||||
| Gm05:35170270 | GNI | 5 | 35170270 | 525.77 | 5.87 | 0.16 | 0.03 | G/A | 7 | Glyma.05g160000 | CESA8 | Cellulose synthase family protein |
|
| MGNI | 1261.72 | 6.05 | 0.17 | 0.03 | 7 | ||||||||
| Gm05:38940662 | GNE | 5 | 38940662 | –0.95 | 5.79 | 5.74 | 0.50 | T/C | 2 | Glyma.05g207000 | GSTT1 | Glutathione S-transferase THETA 1 |
|
| DZI | –117.49 ∼50.67 | 6.22 ∼8.41 | 8.76 ∼14.28 | 0.50 | 2, 3, 4 | ||||||||
| GNI | –83.91 ∼64.22 | 9.82, 10.48 | 9.47, 13.47 | 0.50 | 1, 2 | ||||||||
| MDZI | –316.48 ∼85.11 | 6.32 ∼11.74 | 3.09 ∼10.23 | 0.50 | 1, 2, 3, 4, 5, 6 | ||||||||
| MGNI | –318.26 ∼125.76 | 6.33 ∼8.70 | 4.27 ∼14.98 | 0.50 | 1, 2, 3, 4, 6 | ||||||||
| ADZI | –10.93, 13.81 | 6.47, 9.32 | 11.54, 19.17 | 0.50 | 5, 6 | ||||||||
| TI | –837.84to ∼318.64 | 5.96 ∼12.95 | 6.22 ∼13.84 | 0.50 | 1, 2, 3, 4, 5 | ||||||||
| Gm05:39039365 | GLE | 5 | 39039365 | –3.05, 1.46 | 7.21, 10.00 | 6.26, 13.64 | 0.50 | C/T | 3, 4 | ||||
| GNI | –152.06to ∼47.36 | 5.84 ∼12.93 | 8.33 ∼19.88 | 0.50 | 3, 4, 5, 6 | ||||||||
| ADZI | –31.76 ∼13.62 | 5.80 ∼9.93 | 6.47 ∼14.38 | 0.50 | 1, 3, 4 | ||||||||
| Gm05:41272024 | GLE | 5 | 41272024 | –2.59 | 10.60 | 9.13 | 0.08 | A/T | 4 | ||||
| GNI | –324.75 | 5.77 | 17.04 | 0.08 | 7 | ||||||||
| MGNI | –831.48 | 5.75 | 17.47 | 0.08 | 7 | ||||||||
| Gm08:12085018 | MDZI | 8 | 12085018 | –115.85 | 5.70 | 4.85 | 0.36 | T/G | 2 | Glyma.08g156300 | |||
| ADZI | –12.79, 16.47 | 5.73, 9.94 | 4.65, 7.92 | 0.35, 0.36 | 1, 2 | ||||||||
| Gm09:38479648 | GLE | 9 | 38479648 | –1.7 | 7.25 | 10.71 | 0.16 | T/C | 2 | Glyma.09g160600 | RKL1 | Receptor-like kinase 1 | |
| MDZI | –151.53 | 7.86 | 9.28 | 0.16 | 6 | ||||||||
| Gm10:45467630 | DZE | 10 | 45467630 | 6.46, 8.69 | 5.01, 6.81 | 4.36, 8.21 | 0.50 | A/C | 4, 6 | Glyma.10g223800 | Basic-leucine zipper (bZIP) transcription factor family protein |
| |
| GLE | 8.93 | 6.17 | 11.19 | 0.50 | 5 | ||||||||
| GNE | 8.15 ∼9.52 | 7.54 ∼8.03 | 8.41 ∼9.52 | 0.50 | 1, 4, 6 | ||||||||
| GNI | 397.33, 452.23 | 6.68, 7.82 | 5.82, 10.91 | 0.05 | 1, 2 | ||||||||
| Gm10:49323094 | DZE | 10 | 49323094 | 12.44 ∼16.51 | 6.23 ∼21.67 | 16.85 ∼27.89 | 0.01 ∼0.50 | C/T | 1, 2, 4, 6, 7 | Glyma.10g271000 | Protein of unknown function (DUF1218) | ||
| GNE | 9.88 ∼12.91 | 9.56 ∼12.28 | 12.97 ∼22.62 | 0.05 | 1, 2, 4, 6 | ||||||||
| Gm11:508733 | GNI | 11 | 508733 | –84.23 | 6.59 | 3.42 | 0.05 | A/G | 4 | Glyma.11g007200 | |||
| ADZI | –28.11 | 5.90 | 10.00 | 0.05 | 1 | ||||||||
| Gm11:589619 | GLE | 11 | 589619 | –2.67 | 12.71 | 14.88 | 0.07 | T/A | 2 | ||||
| GNI | –115.94 | 10.84 | 17.65 | 0.07 | 6 | ||||||||
| MGNI | –207.58, 250.58 | 7.47, 10.66 | 11.55, 11.61 | 0.07 | 4, 6 | ||||||||
| Gm14:38439549 | DZI | 14 | 38439549 | 128.52, 147.19 | 6.08, 7.34 | 11.55, 13.48 | 0.50 | A/G | 4,6 | ||||
| GLI | 73.22 | 6.56 | 20.44 | 0.50 | 2 | ||||||||
| Gm15:24347624 | GNI | 15 | 24347624 | –137.63 | 9.52 | 4.64 | 0.04 | C/T | 1 | Glyma.15g200200 | NHX2 | Sodium hydrogen exchanger 2 | |
| TI | –745.38 | 10.76 | 5.32 | 0.04 | 4 | ||||||||
| Gm15:24347662 | MGNI | 15 | 24347662 | –206.83 ∼223.68 | 6.59 ∼8.43 | 6.76 ∼11.11 | 0.06 | T/C | 2, 4, 6 | Glyma.15g200200 | NHX2 | Sodium hydrogen exchanger 2 | |
| ADZI | –21.53 | 5.95 | 9.23 | 0.06 | 6 | ||||||||
| Gm15:47928380 | GNI | 15 | 47928380 | 170.09 | 5.78 | 8.60 | 0.13 | T/C | 3 | Glyma.15g251200 | CONTAINS InterPro DOMAIN/s: Retrotransposon gag protein | ||
| MGNI | 287.69, 438.17 | 6.34, 7.57 | 0.20, 10.91 | 0.06, 0.13 | 2, 7 | ||||||||
| ADZI | 23.82, 45.19 | 6.09, 7.44 | 0.19, 10.06 | 0.06, 0.13 | 3, 7 | ||||||||
| Gm20:8188732 | ADZI | 20 | 8188732 | 37.23 | 7.54 | 9.66 | 0.17 | G/C | 3 | ||||
| TI | 425.48 | 7.93 | 18.31 | 0.17 | 5 | ||||||||
| Gm20:8460978 | GNE | 20 | 8460978 | 1.51 | 10.16 | 11.18 | 0.30 | T/G | 1 | ||||
| GNI | 56.95 | 7.42 | 4.32 | 0.30 | 1 | ||||||||
| MGNI | 304.24 | 6.83 | 8.27 | 0.30 | 3 | ||||||||
| Gm20:8666294 | DZE | 20 | 8666294 | 0.97 | 7.96 | 3.72 | 0.20 | G/A | 4 | Glyma.20g046800 | ATCDPMEK | 4-(cytidine 5’-phospho)-2-C-methyl-D-erithritol kinase |
|
| DZI | 50.37,124.23 | 6.56, 6.95 | 8.99, 10.75 | 0.20 | 3, 5 | ||||||||
| MDZI | 123.66 | 6.40 | 16.67 | 0.20 | 5 | ||||||||
| MGNI | 168.65 | 11.37 | 21.77 | 0.20 | 5 | ||||||||
| ADZI | 17.30 | 8.84 | 14.51 | 0.20 | 6 | ||||||||
| Gm20:16191481 | GNI | 20 | 16191481 | 53.12, 68.88 | 7.24, 8.18 | 4.91, 13.55 | 0.20 | A/G | 4, 6 | ||||
| MDZI | 122.93, 136.86 | 7.21, 13.50 | 7.46, 8.23 | 0.20 | 4, 6 | ||||||||
| ADZI | 14.32 ∼15.48 | 7.78 ∼10.48 | 6.74 ∼10.27 | 0.20 ∼0.21 | 1, 2, 4 |
DZE, daidzein; GLE, glycitein; GNE, Genistein; DZI, daidzin; GLI, glycitin; GNI, genistin; MDZI, malonyl daidzin; MGLI, malonyl glycitin; MGNI, malonyl genistin; ADGI, acetyl daidzin; AGLI, acetyl glycitin; AGNI, acetyl genistin; QTN, Quantitative trait nucleotide; Chr, chromosome; Effect, QTN effect for isoflavone content (μg g–1); R2, phenotype variation; MAF, minor allele frequency. Method 1–7 refers to mrMLM, FastmrMLM, FASTmrEMMA, pLAR-mEB, pKWmEB, and MLM, respectively.
Information about co-detected QTNs for isoflavone contents in 2021 using MLM-based models.
| QTN | Trait | Chr | Position (bp) | Effect | -log10( | R2 | MAF | Allele | Method | Candidate gene | Symbol | Description | References |
| Gm03:40639077 | DZE | 3 | 40639077 | 16.30 | 7.12 | 12.30 | 0.50 | C/A | 1 | Glyma.03g196800 | Nucleic acid-binding, OB-fold-like protein | ||
| GLE | 26.84 ∼29.05 | 11.33 ∼34.53 | 0.35 ∼58.24 | 0.01 ∼0.50 | 1, 2, 4, 7 | ||||||||
| GNE | 33.69 ∼39.51 | 10.28 ∼20.15 | 31.69 ∼57.37 | 0.50 | 1, 2, 4, 7 | ||||||||
| GNI | 613.86 ∼617.89 | 7.09 ∼15.78 | 23.00 ∼26.02 | 0.01 ∼0.50 | 1, 2, 4, 7 | ||||||||
| Gm04:30558742 | DZI | 4 | 30558742 | 281.11 ∼366.70 | 6.36 ∼9.94 | 13.85 ∼19.36 | 0.50 | C/T | 1, 2, 4, 6 | ||||
| GNI | 325.03 ∼374.79 | 6.50 ∼7.50 | 7.03 ∼12.12 | 0.50 | 2, 4, 6 | ||||||||
| MDZI | 971.73 ∼1241.39 | 9.03 ∼10.26 | 14.44 ∼22.13 | 0.50 | 1, 2, 4, 6 | ||||||||
| MGNI | 975.91 ∼1199.61 | 7.15 ∼7.96 | 7.38 ∼15.97 | 0.50 | 1, 2, 4, 6 | ||||||||
| ADZI | 89.22 ∼105.52 | 6.97 ∼9.14 | 5.86 ∼9.46 | 0.50 | 1, 2, 4, 6 | ||||||||
| TI | 2839.91 ∼3212.93 | 7.09 ∼10.72 | 11.79 ∼14.44 | 0.50 | 1, 2, 4, 6, 7 | ||||||||
| Gm05:41272024 | MGNI | 5 | 41272024 | –245.86 to ∼319.44 | 6.64 ∼10.23 | 9.43 ∼18.83 | 0.08 | A/T | 1, 2, 4, 6 | ||||
| ADZI | –19.42, 23.10 | 6.82, 9.50 | 5.69, 12.88 | 0.08 | 1, 6 | ||||||||
| TI | –524.76 to ∼603.99 | 6.81 ∼9.36 | 6.86 ∼13.42 | 0.08 | 2, 4, 6 | ||||||||
| Gm18:56278301 | GNI | 18 | 56278301 | –46.47, ∼38.91 | 5.88, 6.84 | 4.66, 6.07 | 0.33 | T/C | 2, 4 | Glyma.18g281800 | Homeodomain-like superfamily protein | ||
| ADZI | –12.96 | 9.22 | 5.23 | 0.33 | 1 | ||||||||
| Gm20:32811819 | DZI | 20 | 32811819 | 42.23 ∼107.06 | 6.66 ∼8.69 | 12.78 ∼14.84 | 0.30 ∼0.31 | C/T | 1, 2, 6 | ||||
| GNI | 59.81, 68.25 | 8.79, 10.44 | 11.59, 19.26 | 0.30 ∼0.31 | 1, 6 | ||||||||
| MDZI | 93.33 ∼279.11 | 5.88 ∼8.00 | 6.04 ∼11.87 | 0.30 ∼0.31 | 1, 2, 3, 4, 6 | ||||||||
| MGNI | 153.07 ∼204.05 | 9.47 ∼12.31 | 6.37 ∼21.93 | 0.30 ∼0.31 | 1, 2, 4, 6 | ||||||||
| ADZI | 14.10 ∼26.37 | 5.75 ∼10.69 | 5.46 ∼21.18 | 0.30 ∼0.31 | 1, 2, 3, 6 | ||||||||
| TI | 476.50 ∼866.84 | 7.86 ∼12.00 | 8.42 ∼21.35 | 0.30 ∼0.31 | 1, 2, 3, 4, 6 |
DZE, daidzein; GLE, glycitein; GNE, Genistein; DZI, daidzin; GLI, glycitin; GNI, genistin; MDZI, malonyl daidzin; MGLI, malonyl glycitin; MGNI, malonyl genistin; ADGI, acetyl daidzin; AGLI, acetyl glycitin; AGNI, acetyl genistin; QTN, 1Quantitative trait nucleotide; Chr, chromosome; Effect, QTN effect for isoflavone content (μg g–1); R2, phenotype variation; MAF, minor allele frequency. Method 1–7 refers to mrMLM, FastmrMLM, FASTmrEMMA, pLAR-mEB, pKWmEB, and MLM, respectively.
FIGURE 5Linkage disequilibrium (LD) analysis of Gm05:38940662 (GmGSTT1) and variations in isoflavone contents between haplotypes. (A) Genome-wide average LD decay (R2) of MDP; (B) association mapping for Gm05:38940662 and LD analysis based on isoflavone contents; (C) gene models of GmGSTT1 (Glyma.05g206900 and Glyma.05g207000); (D) isoflavone contents in different haplotypes.
FIGURE 6Transcript levels of GmGSTT1 and other isoflavone biosynthetic genes in original cultivar (DB) and its mutant (DB-088), and isoflavone contents. (A) Isoflavone content in DB and DB-088; (B) relative gene transcript levels in DB and DB-088. All data are means ± SD (n = 5). The * p < 0.05, ** < 0.01, and ** < 0.001, Student’s t-test.